FABP-4 has been shown to independently predict inflammation and fibrosis in non-alcoholic fatty liver disease (NAFLD) and may have a direct pathogenic link to disease progression [9, 10]. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatotic liver disease.